In this GEN webinar, our expert speakers will share their journey of implementing intensified technologies and its potential ...

Recipharm and Exela Pharma Sciences entered into an exclusive strategic alliance aimed at enhancing their combined CDMO sterile manufacturing capabilities in the United States. This collaboration will ...

The new InnoviGene™ Suite from Thermo Fisher Scientific is an all-in-one, browser-based platform that offers a suite of Sanger sequencing applications to enable regulatory compliance while increasing ...

Viralgen relies on a proprietary manufacturing platform, advanced applications of data, and broad experience to accelerate production ...

In this GEN webinar, our expert speaker, Dr. Sterling Johnson, will discuss multi-plex blood biomarker assays, new discoveries in AD research from a large-scale study, and opportunities for early ...

In biotherapeutic development, hitting roadblocks due to insufficient developability assessment is a common and costly setback.

A new brain-mapping neurotechnology called Single Transcriptome Assisted Rabies Tracing (START) maps the brain’s neuronal ...

Disruption of the circadian clock may accelerate the progression of colorectal cancer by affecting the gut microbiome and ...

AI-powered analysis of multianalyte liquid biopsies could be an accessible way to improve ovarian cancer screening.

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Study identifies pro-inflammatory macrophage subtype with distinct genetic features in inflamed joints of RA patients.

Prime Medicine will partner with Bristol Myers Squibb (BMS) to develop and commercialize an unspecified number of reagents for ex vivo T-cell therapies through a collaboration that could generate more ...